Tag Archives: Hal Gunn

13Jun/13
Magic of Qu Crohn’s Panel Discussion

Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial

Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial of QBECO SSI for the Treatment of Crohn’s Disease Vancouver, British Columbia – June 11, 2013 – Qu Biologics Inc., a biopharmaceuticalRead More…